Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.
about
Mechanism of action of lenalidomide in hematological malignanciesMissing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodHigh expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic diseaseExpression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone.Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.Immune dysregulation in myelodysplastic syndrome.A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitorsSeroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studyTipifarnib-mediated suppression of T-bet-dependent signaling pathways.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome.Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndromeFailure of hypomethylating agent-based therapy in myelodysplastic syndromes.Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements.Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients.DNA Methyltransferase Inhibition Promotes Th1 Polarization in Human CD4+CD25high FOXP3+ Regulatory T Cells but Does Not Affect Their Suppressive Capacity.
P2860
Q21198872-140331D5-CF9F-45C8-ADD2-1FB9522106E8Q26798389-05D4C568-1BD1-4010-A436-8FAB851EFEF0Q30973354-9A7331F1-96CA-4A18-A3F2-7BE8F1E16A63Q33657377-0FFF1266-1292-46D5-934B-A3EB8F8BE1E4Q33679140-28A6F480-DE08-486D-8D13-06A293AFF4BEQ33702157-8F348994-A34E-4AE7-998E-A7505BF1E4C9Q34273750-F88F93D0-451C-4844-B0B3-38DB75626DBBQ34314830-9EC4E86C-4E3B-4EC6-9A4E-803B23A31A63Q35136867-3F27E440-1819-4171-96D9-66AFBD42669DQ35567932-F583C5BB-5C65-4000-9760-AD0DDB8DA50DQ35804757-33EDD031-E3CA-4BC2-850A-0E8147928D60Q35854697-3262FE0A-6208-43B9-92B9-170E380BF808Q36181770-B1BB1A27-5C39-421F-A77A-FB595DF9472DQ36470196-8E96678C-31EB-470C-AE29-8CD79B518DD0Q37146038-E6240970-8FDE-455A-ACC0-C93B950D7D6EQ37212043-FDDCBDE9-1301-449E-8D88-62B447BAA3D3Q37584833-0F33B746-F7B6-4859-ABF5-F727F4097DB4Q37937816-7E405C59-05FD-4E1E-AAEB-64B3E11084E8Q40592382-C9A28E63-532E-4E09-8F65-8D44A294D646Q40610118-9BDA2EFF-889A-4968-B998-6E67E19472D8Q42036124-399A44E3-7228-4262-AAD5-5A43C6762C96Q55078696-A97D8875-6AE2-4FCB-A0A9-7F87F2FF0FD8
P2860
Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prevalence and clinical associ ...... s in Myelodysplastic Syndrome.
@en
type
label
Prevalence and clinical associ ...... s in Myelodysplastic Syndrome.
@en
prefLabel
Prevalence and clinical associ ...... s in Myelodysplastic Syndrome.
@en
P2093
P2860
P356
P1433
P1476
Prevalence and clinical associ ...... s in Myelodysplastic Syndrome.
@en
P2093
Boulware D
Epling-Burnette PK
Painter JS
Rollison DE
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404590
P577
2007-02-15T00:00:00Z
P5875
P6179
1018417334